JP2019531742A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531742A5
JP2019531742A5 JP2019520685A JP2019520685A JP2019531742A5 JP 2019531742 A5 JP2019531742 A5 JP 2019531742A5 JP 2019520685 A JP2019520685 A JP 2019520685A JP 2019520685 A JP2019520685 A JP 2019520685A JP 2019531742 A5 JP2019531742 A5 JP 2019531742A5
Authority
JP
Japan
Prior art keywords
receptor
antigen
tcr
protein
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019520685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019531742A (ja
JPWO2018073393A5 (https=
JP7236380B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/076800 external-priority patent/WO2018073393A2/en
Publication of JP2019531742A publication Critical patent/JP2019531742A/ja
Publication of JP2019531742A5 publication Critical patent/JP2019531742A5/ja
Publication of JPWO2018073393A5 publication Critical patent/JPWO2018073393A5/ja
Application granted granted Critical
Publication of JP7236380B2 publication Critical patent/JP7236380B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019520685A 2016-10-19 2017-10-19 治療に適したｔａｌエフェクターヌクレアーゼ（ｔａｌｅｎ）改変同種異系細胞 Active JP7236380B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662410187P 2016-10-19 2016-10-19
US62/410,187 2016-10-19
DKPA201770240 2017-03-31
DKPA201770240 2017-03-31
PCT/EP2017/076800 WO2018073393A2 (en) 2016-10-19 2017-10-19 Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy

Publications (4)

Publication Number Publication Date
JP2019531742A JP2019531742A (ja) 2019-11-07
JP2019531742A5 true JP2019531742A5 (https=) 2023-01-25
JPWO2018073393A5 JPWO2018073393A5 (https=) 2023-01-25
JP7236380B2 JP7236380B2 (ja) 2023-03-09

Family

ID=60268352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019520685A Active JP7236380B2 (ja) 2016-10-19 2017-10-19 治療に適したｔａｌエフェクターヌクレアーゼ（ｔａｌｅｎ）改変同種異系細胞

Country Status (5)

Country Link
US (1) US20230138915A1 (https=)
EP (1) EP3529265A2 (https=)
JP (1) JP7236380B2 (https=)
AU (1) AU2017347685B2 (https=)
CA (1) CA3041039A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113015750A (zh) 2018-11-07 2021-06-22 克里斯珀医疗股份公司 抗liv1免疫细胞癌症疗法
CA3185455A1 (en) * 2020-06-11 2021-12-16 Novartis Ag Zbtb32 inhibitors and uses thereof
CN117129690B (zh) * 2023-09-26 2025-06-06 杭州师范大学 Grhl1在her2-乳腺癌诊断及预后评估中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102437522B1 (ko) * 2012-05-25 2022-08-26 셀렉티스 면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법
WO2014191128A1 (en) * 2013-05-29 2014-12-04 Cellectis Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
MX373460B (es) * 2014-03-11 2020-04-07 Cellectis Metodo para generar celulas t compatibles para el trasplante alogenico.
WO2016124765A1 (en) 2015-02-06 2016-08-11 Cellectis Primary hematopoietic cells genetically engineered by slow release of nucleic acids using nanoparticles
KR20260048600A (ko) 2015-03-27 2026-04-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 변형된 t 세포 및 이의 제조 및 사용 방법
CN117070468A (zh) * 2015-10-05 2023-11-17 精密生物科学公司 包含经修饰的人T细胞受体α恒定区基因的经遗传修饰的细胞
IL262365B2 (en) * 2016-04-15 2024-11-01 Alpine Immune Sciences Inc Immunomodulatory proteins ICOS ligand variants and uses thereof

Similar Documents

Publication Publication Date Title
JP7246647B2 (ja) Ｂｃｍａに結合するキメラ抗原受容体（ｃａｒ）及びその応用
IL273201B1 (en) Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy
US20220193135A1 (en) Modified immune effector cell and preparation method therefor
ES3000183T3 (en) Methods for expanding antigen-specific car-t cells, compositions and uses related thereto
AU2017233072B2 (en) Multimodal vector for dendritic cell infection
US12270032B2 (en) Codon-optimized nucleotide sequences encoding an AP-1 transcription factor
IL297547A (en) Therapeutic interventional particles for the corona virus
JP2020517263A5 (https=)
RU2018122106A (ru) Буферы для стабилизации лентивирусных препаратов
JP2021510081A (ja) 抗体修飾キメラ抗原受容体修飾ｔ細胞及びその使用
IL297514A (en) Vectors and methods for in vivo transduction
JP2019531742A5 (https=)
CN110511912A (zh) 免疫细胞的功能调节
WO2023274303A9 (zh) 调控细胞生理活动的嵌合多肽
CN111868077A (zh) Gpi锚定抗原的增强的免疫原性
CN117222421A (zh) T细胞调节多肽和其使用方法
CN112111460A (zh) 修饰的细胞群体的药物组合物
JP7236380B2 (ja) 治療に適したｔａｌエフェクターヌクレアーゼ（ｔａｌｅｎ）改変同種異系細胞
WO2023164688A1 (en) Allogeneic therapeutic cells
JPWO2018073393A5 (https=)
JPWO2020142780A5 (https=)
US20250269012A1 (en) Virus encoding transgenes to complement cellular therapy
WO2025194140A1 (en) Thermally controlled gene expression and uses thereof
HK40115321A (zh) 同种异体治疗性细胞
JP2025517371A (ja) 細胞療法構築物の非ウイルス送達